Menora Mivtachim Holdings’s UroGen Pharma URGN Stock Holding History

Menora Mivtachim Holdings’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$15.8M	Sell	1,152,531 -1,150,500	-50%	-$15.8M	0.09%	77
2025 Q1	$25.5M	Hold	2,303,031	–	–	0.17%	70
2024 Q4	$24.5M	Hold	2,303,031	–	–	0.15%	64
2024 Q3	$29.2M	Hold	2,303,031	–	–	0.18%	57
2024 Q2	$38.6M	Hold	2,303,031	–	–	0.26%	59
2024 Q1	$34.5M	Hold	2,303,031	–	–	0.26%	56
2023 Q4	$34.5M	Hold	2,303,031	–	–	0.29%	57
2023 Q3	$32.3M	Sell	2,303,031 -226,789	-9%	-$3.18M	0.29%	58
2023 Q2	$26.2M	Sell	2,529,820 -389,183	-13%	-$4.03M	0.24%	58
2023 Q1	$27M	Hold	2,919,003	–	–	0.28%	56
2022 Q4	$25.9M	Hold	2,919,003	–	–	0.44%	39
2022 Q3	$24.3M	Sell	2,919,003 -30,486	-1%	-$254K	0.46%	36
2022 Q2	$24.2M	Sell	2,949,489 -3,000	-0.1%	-$24.6K	0.44%	37
2022 Q1	$25.7M	Hold	2,952,489	–	–	0.37%	38
2021 Q4	$28.1M	Sell	2,952,489 -2,210	-0.1%	-$21K	0.38%	41
2021 Q3	$49.7M	Hold	2,954,699	–	–	0.73%	39
2021 Q2	$45.1M	Hold	2,954,699	–	–	0.65%	39
2021 Q1	$57.6M	Hold	2,954,699	–	–	0.94%	36
2020 Q4	$53.2M	Hold	2,954,699	–	–	0.93%	37
2020 Q3	$57M	Hold	2,954,699	–	–	1.27%	37
2020 Q2	$77.2M	Hold	2,954,699	–	–	1.89%	27
2020 Q1	$52.7M	Hold	2,954,699	–	–	1.44%	32
2019 Q4	$98.6M	Hold	2,954,699	–	–	2.35%	14
2019 Q3	$70.4M	Hold	2,954,699	–	–	1.71%	34
2019 Q2	$106M	Hold	2,954,699	–	–	2.87%	8
2019 Q1	$109M	Buy	2,954,699 +454,829	+18%	+$16.8M	2.93%	3
2018 Q4	$108M	Hold	2,499,870	–	–	3.11%	3
2018 Q3	$118M	Hold	2,499,870	–	–	3.2%	3
2018 Q2	$124M	Buy	2,499,870 +454,241	+22%	+$22.6M	3.53%	4
2018 Q1	$102M	Buy	2,045,629 +535,622	+35%	+$26.6M	3.22%	5
2017 Q4	$56.2M	Buy	1,510,007 +940,418	+165%	+$35M	2.17%	9
2017 Q3	$18M	Buy	569,589 +440,534	+341%	+$13.9M	0.73%	52
2017 Q2	$2.33M	Buy	+129,055	New	+$2.33M	0.11%	58